BRCA1 and BRCA2 in breast cancer families from Wales: moderate mutation frequency and two recurrent mutations in BRCA1
1998

BRCA1 and BRCA2 Mutations in Welsh Breast Cancer Families

Sample size: 17 publication Evidence: moderate

Author Information

Author(s): JM Lancaster, ME Carney, J Gray, J Myring, C Gumbs, J Sampson, D Wheeler, E France, R Wiseman, P Harper, PA Futreal

Primary Institution: Duke University Medical Center

Hypothesis

What is the mutation frequency of BRCA1 and BRCA2 in breast cancer families from Wales?

Conclusion

The study found that 47% of the Welsh families screened had mutations in BRCA1 or BRCA2, indicating a moderate mutation frequency.

Supporting Evidence

  • Eight out of 17 families had demonstrable mutations.
  • Six families carried BRCA1 mutations and two carried BRCA2 mutations.
  • Two recurrent mutations in BRCA1 were identified, suggesting founder mutations in this population.
  • Families with mutations had an average breast cancer diagnosis age of 40.7 years.

Takeaway

The researchers looked at families in Wales with breast cancer and found that almost half had mutations in two important genes that can cause cancer.

Methodology

The study screened 17 families for mutations in BRCA1 and BRCA2 using various genetic analysis techniques.

Limitations

The study did not identify all possible mutations, suggesting that other cancer susceptibility genes may exist.

Participant Demographics

Families from Wales with two or more cases of breast cancer under age 50 and/or ovarian cancer.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication